Circadian Rhythm Sleep Disorders
2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
VP
Vanda PharmaceuticalsWASHINGTON, DC
2 programs1
1
VEC-162Phase 21 trial
tasimelteonPhase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Vanda PharmaceuticalsVEC-162
Vanda Pharmaceuticalstasimelteon
Clinical Trials (2)
Total enrollment: 69 patients across 2 trials
Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers
Start: Jul 2004Est. completion: Mar 200545 patients
Phase 2Completed
Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents
Start: Oct 2016Est. completion: Dec 201724 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space